GVS (GVSM) Stock Overview
Produces and sells filter solutions for applications in the healthcare and life sciences, energy and mobility, and health and safety sectors in Italy and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
GVSM Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
GVS S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.46 |
| 52 Week High | €4.46 |
| 52 Week Low | €4.46 |
| Beta | 1.06 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -52.12% |
| 5 Year Change | -58.76% |
| Change since IPO | -59.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| GVSM | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.9% | -1.1% |
| 1Y | n/a | -0.05% | 10.1% |
Return vs Industry: Insufficient data to determine how GVSM performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how GVSM performed against the UK Market.
Price Volatility
| GVSM volatility | |
|---|---|
| GVSM Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: GVSM's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine GVSM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 4,234 | Massimo Scagliarini | www.gvs.com |
GVS S.p.A., together with its subsidiaries, produces and sells filter solutions for applications in the healthcare and life sciences, energy and mobility, and health and safety sectors in Italy and internationally. The company offers health and safety products, such as hand dryer and vacuum cleaner filters; nailstation COSMO products; fume extraction and HVAC building products; and disposable masks, half masks, integra masks, powered air purifying respirators, face fit testing, replacement filters, supplied air respirators, spare parts, and accessories. It also provides autoclave filters, insufflation and ventilation filters and kits, machine filters, respiratory and anesthesia filters, smoke evacuation filters and kits, spirometry filters and accessories, suction filters, and tracheal humidifier filters; healthcare liquid products, such as bacterial air vents, blood tubular filters, infusion disc filters, IV and liquid filters, IV flow regulators, medical bags and components, sterile infusion sets and accessories, stopcock and manifold products, and transducer protectors; and capsule and cartridge filters, disc and sheet membranes, mini roll membranes, DNA/RNA test kits, filter papers, microbiology products, microfiltration devices, microporous and track etched roll membranes, protein microarrays, and environmental monitoring products, as well as western blotting membranes and reagents.
GVS S.p.A. Fundamentals Summary
| GVSM fundamental statistics | |
|---|---|
| Market cap | €948.10m |
| Earnings (TTM) | €25.81m |
| Revenue (TTM) | €431.86m |
Is GVSM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GVSM income statement (TTM) | |
|---|---|
| Revenue | €431.86m |
| Cost of Revenue | €191.62m |
| Gross Profit | €240.24m |
| Other Expenses | €214.42m |
| Earnings | €25.81m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Aug 07, 2025
| Earnings per share (EPS) | 0.14 |
| Gross Margin | 55.63% |
| Net Profit Margin | 5.98% |
| Debt/Equity Ratio | 63.4% |
How did GVSM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/30 07:07 |
| End of Day Share Price | 2025/06/03 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
GVS S.p.A. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gabriele Venturi | Banca Akros S.p.A. (ESN) |
| Gerhard Orgonas | Berenberg |
| Anna Frontani | Berenberg |